Persistent pulmonary hypertension in a very low birthweight preterm infant.
Persistent pulmonary hypertension of the neonate (PPHN) characteristically is seen in full-term or postterm infants. Occasionally, PPHN complicates the course of hyaline membrane disease in preterm infants. This report documents the unusual occurrence of PPHN in a preterm very low birthweight infant without apparent pulmonary parenchymal disease.
D000527:Alprostadil; D004298:Dopamine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D010102:Oxygen Inhalation Therapy; D010547:Persistent Fetal Circulation Syndrome / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D011458:Prostaglandins E / Q000627:therapeutic use; D014043:Tolazoline / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D011458:Prostaglandins E; D014665:Vasodilator Agents; D014043:Tolazoline; D000527:Alprostadil; D004298:Dopamine